Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Varrone

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Neuroimage|July 12, 2008
Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2Akihiro Takano, Andrea Varrone, Balázs Gulyás, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 21, 2025
Correcting <i>SUVR</i> bias by accounting for radiotracer clearance in tissue: A validation study with [<sup>18</sup>F]FE-PE2I PET in cross-sectional, test-retest and longitudinal cohortsMinyoung Oh, Praveen Honhar, Richard E Carson, et al.
EJNMMI Research|April 5, 2023
[<sup>18</sup>F]FE-PE2I DAT correlates with Parkinson's disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation studyVera S Kerstens, Patrik Fazio, Mathias Sundgren, et al.
Nuclear Medicine and Biology|October 29, 2011
Simplified quantification and whole-body distribution of [18F]FE-PE2I in nonhuman primates: prediction for human studiesAndrea Varrone, Balázs Gulyás, Akihiro Takano, et al.
Human Brain Mapping|October 2, 2010
Extrastriatal dopamine D(2) receptor binding in Huntington's diseaseMouna Esmaeilzadeh, Lars Farde, Per Karlsson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease PatientsIda Sonni, Patrik Fazio, Martin Schain, et al.
EJNMMI Research|July 23, 2017
Assessment of simplified ratio-based approaches for quantification of PET [<sup>11</sup>C]PBR28 dataGranville J Matheson, Pontus Plavén-Sigray, Anton Forsberg, et al.
Neuroimage|January 10, 2012
Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systemsMartin Schain, Miklós Tóth, Zsolt Cselényi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 6, 2020
High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson's disease cohortPatrik Fazio, Daniel Ferreira, Per Svenningsson, et al.
Talanta|December 11, 2019
New approach in radiometabolite analysis of positron emission tomography (PET) radioligands; lead-shielded microextraction by packed sorbent as a tool for in vivo radiometabolite analysis of [<sup>11</sup>C]SMW139 in rat plasmaMohammad Mahdi Moein, Miklós Tóth, Lenke Tari, et al.
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Neuroimage|July 12, 2008
Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2Akihiro Takano, Andrea Varrone, Balázs Gulyás, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 21, 2025
Correcting <i>SUVR</i> bias by accounting for radiotracer clearance in tissue: A validation study with [<sup>18</sup>F]FE-PE2I PET in cross-sectional, test-retest and longitudinal cohortsMinyoung Oh, Praveen Honhar, Richard E Carson, et al.
EJNMMI Research|April 5, 2023
[<sup>18</sup>F]FE-PE2I DAT correlates with Parkinson's disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation studyVera S Kerstens, Patrik Fazio, Mathias Sundgren, et al.
Nuclear Medicine and Biology|October 29, 2011
Simplified quantification and whole-body distribution of [18F]FE-PE2I in nonhuman primates: prediction for human studiesAndrea Varrone, Balázs Gulyás, Akihiro Takano, et al.
Human Brain Mapping|October 2, 2010
Extrastriatal dopamine D(2) receptor binding in Huntington's diseaseMouna Esmaeilzadeh, Lars Farde, Per Karlsson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease PatientsIda Sonni, Patrik Fazio, Martin Schain, et al.
EJNMMI Research|July 23, 2017
Assessment of simplified ratio-based approaches for quantification of PET [<sup>11</sup>C]PBR28 dataGranville J Matheson, Pontus Plavén-Sigray, Anton Forsberg, et al.
Neuroimage|January 10, 2012
Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systemsMartin Schain, Miklós Tóth, Zsolt Cselényi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 6, 2020
High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson's disease cohortPatrik Fazio, Daniel Ferreira, Per Svenningsson, et al.
Talanta|December 11, 2019
New approach in radiometabolite analysis of positron emission tomography (PET) radioligands; lead-shielded microextraction by packed sorbent as a tool for in vivo radiometabolite analysis of [<sup>11</sup>C]SMW139 in rat plasmaMohammad Mahdi Moein, Miklós Tóth, Lenke Tari, et al.
Pageof 17